Skip to main content
. 2026 Jul 29;28:41. doi: 10.1186/s12575-026-00353-1

Fig. 2.

Fig. 2

Network pharmacology analysis and functional enrichment analysis of ZZD (ZS-BZ) for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). A Network diagram illustrating the interactions among traditional Chinese medicine (TCM) active ingredients, overlapping gene targets, and the disease. Note: Blue diamonds represent TCM compounds or active ingredients, green ellipses represent target proteins, where darker shading and larger node size indicate greater importance. B Venn diagram of targets shared between ZZD and IBS-C. C The top 13 targets ranked by degree value. D Protein–protein interaction (PPI) network. E Biological process (BP) analysis of targets for ZZD in the treatment of IBS-C (top 20 terms). Note: the horizontal axis represents the gene ratio, and the vertical axis represents the enriched BP terms; bars are sorted from smallest to largest P-value. F Cellular component (CC) analysis of targets for ZZD in the treatment of IBS-C (top 20 terms). Note: the horizontal axis represents the gene ratio, and the vertical axis represents the enriched CC terms; bars are sorted from smallest to largest P-value. G Molecular function (MF) analysis of targets for ZZD in the treatment of IBS-C (top 20 terms). H Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of targets for ZZD in the treatment of IBS-C (top 19 terms). Note: the horizontal axis represents the gene ratio, and the vertical axis represents the enriched KEGG pathways; bars are sorted from smallest to largest P-value